ロード中...
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
The improvement in outcomes of adult patients with acute lymphoblastic leukemia (ALL) has been modest, with the exception of Philadelphia chromosome-positive disease, despite advances in supportive care and stem cell transplantation. The recent approvals of novel agents, including the bispecific T-c...
保存先:
| 出版年: | J Blood Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5908210/ https://ncbi.nlm.nih.gov/pubmed/29713210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S136575 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|